Ohoka N[au] - Search Results

Year	Number of Results
2003	2
2005	1
2007	3
2008	2
2009	1
2010	4
2011	2
2012	1
2013	2
2014	2
2015	3
2016	7
2017	10
2018	7
2019	9
2020	5
2021	7
2022	7
2023	4
2024	3

1

SNIPERs-Hijacking IAP activity to induce protein degradation.

Naito M, Ohoka N, Shibata N. Naito M, et al. Among authors: ohoka n. Drug Discov Today Technol. 2019 Apr;31:35-42. doi: 10.1016/j.ddtec.2018.12.002. Epub 2019 Jan 14. Drug Discov Today Technol. 2019. PMID: 31200857 Free article. Review.

2

Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs.

Naito M, Ohoka N, Shibata N, Tsukumo Y. Naito M, et al. Among authors: ohoka n. Front Chem. 2019 Dec 10;7:849. doi: 10.3389/fchem.2019.00849. eCollection 2019. Front Chem. 2019. PMID: 31921772 Free PMC article. Review.

3

Development of a Potent Protein Degrader against Oncogenic BCR-ABL Protein.

Shibata N, Ohoka N, Hattori T, Naito M. Shibata N, et al. Among authors: ohoka n. Chem Pharm Bull (Tokyo). 2019;67(3):165-172. doi: 10.1248/cpb.c18-00703. Chem Pharm Bull (Tokyo). 2019. PMID: 30827996 Free article. Review.

4

Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy.

Ohoka N, Shibata N, Hattori T, Naito M. Ohoka N, et al. Curr Cancer Drug Targets. 2016;16(2):136-46. doi: 10.2174/1568009616666151112122502. Curr Cancer Drug Targets. 2016. PMID: 26560118 Review.

5

[Development of Protein Knockdown Technology as Emerging Drug Discovery Strategy].

Ohoka N. Ohoka N. Yakugaku Zasshi. 2018;138(9):1135-1143. doi: 10.1248/yakushi.18-00113. Yakugaku Zasshi. 2018. PMID: 30175757 Free article. Review. Japanese.

6

Development of Agonist-Based PROTACs Targeting Liver X Receptor.

Xu H, Ohoka N, Yokoo H, Nemoto K, Ohtsuki T, Matsufuji H, Naito M, Inoue T, Tsuji G, Demizu Y. Xu H, et al. Among authors: ohoka n. Front Chem. 2021 May 26;9:674967. doi: 10.3389/fchem.2021.674967. eCollection 2021. Front Chem. 2021. PMID: 34124002 Free PMC article.

7

Structure-Activity Relationship Study of Helix-Stabilized Antimicrobial Peptides Containing Nonproteinogenic Amino Acids.

Ito T, Hashimoto W, Ohoka N, Misawa T, Inoue T, Kawano R, Demizu Y. Ito T, et al. Among authors: ohoka n. ACS Biomater Sci Eng. 2023 Aug 14;9(8):4654-4661. doi: 10.1021/acsbiomaterials.3c00759. Epub 2023 Jul 24. ACS Biomater Sci Eng. 2023. PMID: 37486982

8

Development of ciclesonide analogues that block SARS-CoV-2 RNA replication.

Tsuji G, Yonemitsu K, Ito T, Yanase Y, Uema M, Ohoka N, Inoue T, Asakura H, Demizu Y. Tsuji G, et al. Among authors: ohoka n. Bioorg Med Chem Lett. 2021 Jul 1;43:128052. doi: 10.1016/j.bmcl.2021.128052. Epub 2021 Apr 20. Bioorg Med Chem Lett. 2021. PMID: 33887440 Free PMC article.

9

Development of STING degrader with double covalent ligands.

Nakamura M, Ohoka N, Shibata N, Inoue T, Tsuji G, Demizu Y. Nakamura M, et al. Among authors: ohoka n. Bioorg Med Chem Lett. 2024 Apr 1;102:129677. doi: 10.1016/j.bmcl.2024.129677. Epub 2024 Feb 24. Bioorg Med Chem Lett. 2024. PMID: 38408510

10

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication.

Tsuji G, Nakajima S, Watashi K, Torii S, Suzuki R, Fukuhara T, Ohoka N, Inoue T, Demizu Y. Tsuji G, et al. Among authors: ohoka n. J Pharmacol Sci. 2022 Jul;149(3):81-84. doi: 10.1016/j.jphs.2022.04.001. Epub 2022 Apr 18. J Pharmacol Sci. 2022. PMID: 35641031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year